Acetic Anhydride → HCID 58529708, compound
Reaction equation
[CH2:1]([N:8]1[CH:16]=[C:15]2[C:10]([CH:11]=[C:12]([C:17]3[CH:18]=[C:19]([CH:27]4[CH2:31][CH2:30][NH:29][CH2:28]4)[N:20]4[C:25]=3[C:24]([NH2:26])=[N:23][CH:22]=[N:21]4)[CH:13]=[CH:14]2)=[N:9]1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[C:32](OC(=O)C)(=[O:34])[CH3:33]>>[C:32]([N:29]1[CH2:30][CH2:31][CH:27]([C:19]2[N:20]3[C:25]([C:24]([NH2:26])=[N:23][CH:22]=[N:21]3)=[C:17]([C:12]3[CH:13]=[CH:14][C:15]4[C:10]([CH:11]=3)=[N:9][N:8]([CH2:1][C:2]3[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=3)[CH:16]=4)[CH:18]=2)[CH2:28]1)(=[O:34])[CH3:33]Participants
3
Procedure
5-(2-benzyl-2H-indazol-6-yl)-7-pyrrolidin-3-ylpyrrolo[2,1-f][1,2,4]triazin-4-amine (40 mg, 0.098 mmol) was reacted with acetic anhydride (13 mg, 0.127 mmol) following the procedure of Example 107. The product was chromatographed on an ISCO® instrument (4 g column). The eluent was 0-6% (2N NH3 in methanol)/dichloromethane to yield 18 mg (41%) of desired product. 1H NMR (300 MHz, DMSO-d6) δ 8.62 (s, 1 H), 8.00-7.75 (m, 4 H), 7.60-7.40 (m, 4H), 7.23 (d, 1 H), 6.77 (d, 1 H), 5.72 (s, 2 H), 4.10-3.20 (m, 5H), 2.52-2.15 (m, 2H), 2.05 (s, 3 H); ES-MS m/z 452.4 [M+H]+, HPLC RT (min) 2.36.
Workup
- customThe product was chromatographed on an ISCO® instrument (4 g column)
Sources & evidence
- ORD record
- ord-497e82e9a1c640c985de3686344d95cc
- Source dataset
- uspto-grants-2013_04
- Patent number
- US08431695B2
Reaction notes
Loading…